INTEGRILIN

What this means for you

Registered since 23 Mar 1999. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Mar 2029: the §8 & §9 renewal).

Record

Serial number

75009658

Registration number

2234543

Mark type

Word mark

Filed

11 Oct 1995

Published for opposition

25 Jun 1996

Registered

23 Mar 1999

Current term from

23 Mar 2019

Next maintenance filing

§8 & §9 renewal, due by 23 Mar 2029 (grace period to 23 Sept 2029)

Attorney of record

Nancy DiConza

Goods and services

• Class 005 — Pharmaceuticals: pharmaceuticals, namely cardiovascular preparations

Owner

• MILLENNIUM PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
• COR Therapeutics, Inc., South San Francisco, CA, US
• COR Therapeutics, Inc., South San Francisco, CA, US
• COR Therapeutics, Inc., South San Francisco, CA, US

Board proceedings on this mark

• Opposition No. 91102682 — ROBERTS LABORATORIES, INC. v. COR THERAPEUTICS, INC., filed 23 Jul 1996 (Terminated)

The owner also pleads this mark in 1 other Board proceeding.

Prosecution history

• 23 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 23 Apr 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
• 23 Apr 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 23 Apr 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 21 Mar 2019 — TEAS SECTION 8 & 9 RECEIVED
• 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
• 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 14 May 2008 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 14 May 2008 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 06 May 2008 — ASSIGNED TO PARALEGAL
• 24 Apr 2008 — TEAS SECTION 8 & 9 RECEIVED
• 08 Mar 2005 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 27 Jan 2005 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
• 27 Jan 2005 — PAPER RECEIVED
• 23 Mar 1999 — REGISTERED-PRINCIPAL REGISTER